Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma

医学 异柠檬酸脱氢酶 回顾性队列研究 队列 胶质母细胞瘤 内科学 磁共振成像 IDH1 肿瘤科 队列研究 外科 放射科 突变 基因 酶 化学 癌症研究 生物化学
作者
Annette M. Molinaro,Shawn L. Hervey‐Jumper,Ramin A. Morshed,Jacob S. Young,Seunggu J. Han,Pranathi Chunduru,Yalan Zhang,Joanna J. Phillips,Anny Shai,Marisa Lafontaine,Jason C. Crane,Ankush Chandra,Patrick M. Flanigan,Arman Jahangiri,Gino Cioffi,Quinn T. Ostrom,John E. Anderson,Chaitra Badve,Jill S. Barnholtz‐Sloan,Andrew E. Sloan
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:6 (4): 495-495 被引量:634
标识
DOI:10.1001/jamaoncol.2019.6143
摘要

Importance: Per the World Health Organization 2016 integrative classification, newly diagnosed glioblastomas are separated into isocitrate dehydrogenase gene 1 or 2 (IDH)-wild-type and IDH-mutant subtypes, with median patient survival of 1.2 and 3.6 years, respectively. Although maximal resection of contrast-enhanced (CE) tumor is associated with longer survival, the prognostic importance of maximal resection within molecular subgroups and the potential importance of resection of non-contrast-enhanced (NCE) disease is poorly understood. Objective: To assess the association of resection of CE and NCE tumors in conjunction with molecular and clinical information to develop a new road map for cytoreductive surgery. Design, Setting, and Participants: This retrospective, multicenter cohort study included a development cohort from the University of California, San Francisco (761 patients diagnosed from January 1, 1997, through December 31, 2017, with 9.6 years of follow-up) and validation cohorts from the Mayo Clinic (107 patients diagnosed from January 1, 2004, through December 31, 2014, with 5.7 years of follow-up) and the Ohio Brain Tumor Study (99 patients with data collected from January 1, 2008, through December 31, 2011, with a median follow-up of 10.9 months). Image accessors were blinded to patient groupings. Eligible patients underwent surgical resection for newly diagnosed glioblastoma and had available survival, molecular, and clinical data and preoperative and postoperative magnetic resonance images. Data were analyzed from November 15, 2018, to March 15, 2019. Main Outcomes and Measures: Overall survival. Results: Among the 761 patients included in the development cohort (468 [61.5%] men; median age, 60 [interquartile range, 51.6-67.7] years), younger patients with IDH-wild-type tumors and aggressive resection of CE and NCE tumors had survival similar to that of patients with IDH-mutant tumors (median overall survival [OS], 37.3 [95% CI, 31.6-70.7] months). Younger patients with IDH-wild-type tumors and reduction of CE tumor but residual NCE tumors fared worse (median OS, 16.5 [95% CI, 14.7-18.3] months). Older patients with IDH-wild-type tumors benefited from reduction of CE tumor (median OS, 12.4 [95% CI, 11.4-14.0] months). The results were validated in the 2 external cohorts. The association between aggressive CE and NCE in patients with IDH-wild-type tumors was not attenuated by the methylation status of the promoter region of the DNA repair enzyme O6-methylguanine-DNA methyltransferase. Conclusions and Relevance: This study confirms an association between maximal resection of CE tumor and OS in patients with glioblastoma across all subgroups. In addition, maximal resection of NCE tumor was associated with longer OS in younger patients, regardless of IDH status, and among patients with IDH-wild-type glioblastoma regardless of the methylation status of the promoter region of the DNA repair enzyme O6-methylguanine-DNA methyltransferase. These conclusions may help reassess surgical strategies for individual patients with newly diagnosed glioblastoma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
lethe发布了新的文献求助10
1秒前
Owen的应助被聪慧含芙采纳,获得10
1秒前
Huzy发布了新的文献求助10
2秒前
无花果的应助被周一采纳,获得10
2秒前
杨茜然发布了新的文献求助10
3秒前
隐形曼青的应助被困就睡觉采纳,获得10
3秒前
锝奕完成签到,获得积分10
4秒前
许大脚发布了新的文献求助10
5秒前
慕青的应助被车厘子采纳,获得20
6秒前
6秒前
6秒前
一团毛线发布了新的文献求助10
7秒前
7秒前
zht完成签到,获得积分10
7秒前
7秒前
123发布了新的文献求助10
9秒前
哈哈发布了新的文献求助10
9秒前
单薄的冥茗完成签到,获得积分10
10秒前
10秒前
lf-leo完成签到,获得积分10
10秒前
11秒前
Lucas的应助被DXL采纳,获得30
11秒前
wmc666发布了新的文献求助10
11秒前
11秒前
12秒前
大坏猫路西法完成签到,获得积分10
12秒前
隐形曼青的应助被赵妍采纳,获得10
12秒前
史卓曼发布了新的文献求助10
13秒前
可爱的函函的应助被冬至采纳,获得30
13秒前
参商完成签到,获得积分10
13秒前
呼吸阳光发布了新的文献求助20
13秒前
秧央完成签到,获得积分10
14秒前
有魅力的秋荷完成签到,获得积分20
14秒前
杨志发布了新的文献求助10
14秒前
无限的晓绿完成签到,获得积分10
15秒前
科研通AI6.2的应助被zuo20050727采纳,获得10
16秒前
16秒前
完美世界的应助被daigang采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193438
求助须知:如何正确求助?哪些是违规求助? 9579666
关于积分的说明 21866723
捐赠科研通 7793099
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560719
邀请新用户注册赠送积分活动 2484156